OncoImmunome / University of Connecticut - LARVOL DELTA

Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma (clinicaltrials.gov) - P1 | N=8 | Terminated | Sponsor: UConn Health | N=15 ➔ 8 | Trial completion date: Oct 2026 ➔ Aug 2022 | Suspended ➔ Terminated | Trial primary completion date: Oct 2026 ➔ Aug 2022; Study recruitment is temporary on hold by the sponsor due to patient recruitment challenges and the ongoing review of the investigational adjuvant.

Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Oncology • Ovarian Cancer • Solid Tumor

Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma (clinicaltrials.gov) - P1; N=15; Suspended; Sponsor: UConn Health; Recruiting ➔ Suspended

Trial suspension • Oncology • Ovarian Cancer • Solid Tumor